Put companies on watchlist
Neogen
ISIN: US6404911066
WKN: 883297
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Neogen · ISIN: US6404911066 · PR Newswire (ID: 20240829DE93831)
29 August 2024 02:45PM

Neogen® To Participate in 2024 Wells Fargo Healthcare Conference


LANSING, Mich., Aug. 29, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 5.

David Naemura, Neogen's Chief Financial Officer, will present at 3:00 PM Eastern Time.

To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Media Contact

Bill Waelke, Vice President, IR & Treasury

IR@Neogen.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-to-participate-in-2024-wells-fargo-healthcare-conference-302233467.html

SOURCE Neogen Corporation

Visual performance / price development - Neogen
Smart analysis and research tools can be found here.
MIC: XNAS
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942